Radio Advisory

Survey insights: 6 priorities for health system strategists in 2024

Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

224: The $400M referral problem (and steps to fixing it) Oct 01, 2024

Two weeks ago on Radio Advisory, we told our listeners that the number one area of focus for health system growth is operational excellence, and a major part of that is capturing all of the revenue on the table from your medical group. Healthcare organizations have spent the last decade buying up medical groups and physicians, in part because of the “promise” of downstream referrals. It is a long-held belief that physician employment leads to higher referral integrity. But according to an Advisory Board data analysis, that doesn’t hold true - just 55% of total referral revenue attributed to employed PCPs is realized in-network.

This week, host Rachel (Rae) Woods invites Advisory Board physician experts Eliza Dailey and Colleen Wagner to unpack where referral leakage actually happens and share the real (and relatively easy) steps organizations can take to reduce referral leakage.

Links:

Survey insights: 6 priorities for health system strategists in 2024

Digital surgery: A way for orthopaedic programs to set themselves apart

A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

223: What would it take for home-based care to take off? With Medically Home's Dr. Matt Richards Sep 24, 2024

In the midst of the COVID-19 pandemic, The Centers for Medicare & Medicaid services released the Acute Hospital Care at Home payment waiver. The action was expected to usher in a new era of home-based care. But while it’s certainly grown in recent years, frankly, that massive shift hasn’t happened. The question is, why?

This week, host Abby Burns invites Dr. Matthew Richards, Senior Medical Director of home-care enablement company Medically Home, to explore the role that home-base care could play in the future of healthcare, and to unpack the misconceptions that prevent home-based care from playing a larger role in the healthcare ecosystem today.

Links:

Survey insights: 6 priorities for health system strategists in 2024

A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

[Encore] What the industry is (still) getting wrong about value-based care Sep 17, 2024

(This episode originally aired on September 26, 2023.)

Value-based care has been dominating industry conversations in recent years. Here on Radio Advisory, we talk a lot about best practices, how to make the right investments, and how to best prepare leaders for the future of value-based care. But given all this momentum, we want to spend time asking the question: what are the misconceptions or misaligned expectations that leaders have around value-based care?

In this episode, host Rachel (Rae) Woods invites Advisory Board value-based care expert Daniel Kuzmanovich and Optum Advisory Service's SVP of value-based care, Erik Johnson, to discuss the mindset shifts they think leaders should be making when pursuing a sustainable value-based care strategy. Throughout the conversation they discuss what leaders are currently getting wrong, how myths about value-based care are impacting the industry, and more.

Links:

3 strategies for a successful sleep apnea therapy program: Lessons from ENTTX's ASC partnership

Survey insights: 6 priorities for health system strategists in 2024

Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

222: It's not just GLP-1s; here's what comprehensive weight management looks like Sep 10, 2024

In the last few years, all eyes have turned to GLP-1s as an industry-altering answer to obesity treatment and weight management. But the fact is, these drugs can’t – and shouldn’t – work in a vacuum. There is a fear that attention on GLP-1s may even blind leaders to the other services that go into providing effective obesity care. So, what should leaders be thinking about when designing and and delivering effective obesity care?

To answer that question, host Abby Burns invites Advisory Board experts Chloe Bakst, Payton Grimes, and Atticus Raasch to unpack what comprehensive weight management programs look like in practice, and why—if done well— they can benefit patients, clinicians, and health systems.

Links:

Learn more about On-demand Courses

A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

221: How will health system growth look different in 2025 and beyond? Sep 03, 2024

When we talk about “health systems,” it can sound like we’re talking about a monolith. But in reality, the $1.4 trillion dollar health system sector is made up of a diverse range of players. Academics and safety nets; urban and rural systems; 1,000-bed systems and 25-bed critical access hospitals. The question is, especially as systems emerge from the financial hardships of the past few years, how do those differences translate to the ways systems are running at growth?

In this episode, the third and final installment in our series leading up to Advisory Board’s Strategy Summit, host Abby Burns invites Advisory Board health system experts Elizabeth Orr and Marisa Nives to unpack how leaders across the health system sector are thinking differently about growing in 2025 and beyond.

Links:

Join us at the Pivots for a Sustainable Future Summit on September 10-11, 2024.

Learn more about Advisory Board Sponsorship.

A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

220: Why AI in healthcare is more than just ChatGPT Aug 27, 2024

We’ve talked a lot about AI on Radio Advisory, with a particular emphasis on generative models and their capabilities. But are there other models of AI that are flying under the radar? Today’s episode focuses on computer vision and its potential to shift how we think about the use of technology in healthcare.

For the second episode in our series leading up to Advisory Board’s upcoming Strategy Summit, host Abby Burns invites digital health experts Ty Aderhold and Elysia Culver to break down why computer vision should be on our minds, arguably just as much as generative AI.

Links:

Join us at the Pivots for a Sustainable Future Summit on September 10-11, 2024.

Register for the How to harness the potential of digital experience in healthcare webinar on September 17.

A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

219: The business case for going green Aug 20, 2024

It's no secret that climate change has had a massive effect on population health, but it’s also impacting healthcare business. Did you know that energy costs have gone up by 28% in the past five years? Health systems in particular can shave percentage points off their annual costs by reducing their energy consumption—but there is both a knowledge gap and an action gap keeping leaders from taking advantage of the opportunity.

Advisory Board’s Strategy Summit on September 10-11 is all about the pivots health systems need to make for a sustainable future – no better way to kick off our lead-up to the event than by taking that quite literally and talking about environmental sustainability.

In this episode, host Abby Burns invites Advisory Board expert Miles Cottier to break down how and why health business leaders need to prioritize environmental sustainability. They explore the financial case for moving to renewable energy sources, how regulatory pressures may (or may not) shape the future of environmental action, and what leaders can do today to support their green initiatives.

Links:

Join us at the Pivots for a Sustainable Future Summit on September 10-11, 2024

A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

218: [Encore + bonus content] Site-of-care shifts: It's time to go on offense Aug 13, 2024

This week, host Abby Burns invites Advisory Board expert Sebastian Beckmann back to Radio Advisory to provide an update—as promised—on what his team has uncovered about site-of-care shifts in the six months since he first brought this research to the pod. Hint: there’s about $50B at play.

This episode is a modified encore of Episode 195: Site-of-care shifts: It’s time to go on offense.” In that episode, Sebastian and fellow Advisory Board expert Nick Hula joined Abby to break down how health systems should be thinking about site-of-care shifts as a part of their growth strategies, including making the transition from a “defensive” mindset to prevent volume shifts, to an “offensive” mindset to capture them.

The original episode will play almost in its entirety, with interjections from Abby and Sebastian to dig deeper into what the site-of-care shift opportunity—or risk—actually looks like across markets and services.

Links:

Learn more about On-demand Courses

Use the Market Scenario Planner

A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

[Encore] Test, fail, and test again: Morgan Health's approach to employer costs Aug 06, 2024

(This episode originally aired on September 12, 2023.)

With rising costs and tightening margins, the industry is continually looking for ways to "bend the cost curve" while maintaining, or even increasing, quality and performance. One stakeholder in particular, employers, are feeling significant pressures from inflation, hospital consolidation, the rise of high-cost drugs, and more. While many legacy cost-saving strategies have focused on reducing employer costs, it may be time to shift focus to lowering costs for employees as well.

In this episode, host Rachel (Rae) Woods invites Advisory Board payer expert Max Hakanson and Innovation lead at JPMorgan's Morgan Health Rivka Friedman to discuss what employers can do to rein in healthcare costs, both for themselves and their employees. Throughout the discussion, they discuss why legacy cost-sharing strategies may be insufficient, and what new innovations are showing promise in the market.

Links:

Learn more about Advisory Board Sponsorship

[Encore] Why can't providers and plans just get along? Jul 30, 2024

(This episode originally aired on March 12, 2024.)

The relationship between health plans and providers has always included an element of friction, but lately, it seems like the temperature is rising. And you've probably noticed – public contracting disputes increased by 69% between 2022 and 2023.

That's why, in this episode, host Abby Burns invites Advisory Board experts Max Hakanson and Eileen Fennell to discuss why the state of affairs seems to be getting worse, how key flashpoints are fanning the flames, and what each stakeholder says they need to see from their partners in order to mend the relationship. Plus, Advisory Board digital health expert Ty Aderhold makes a cameo appearance to help answer the question: Is AI the solution here?

Links:

Learn about the Advisory Board Fellowship

217: How to make innovation real: Live from Advisory Board's Clinical Innovation Summit Jul 23, 2024

Healthcare leaders have dozens of priorities on their plates, and achieving innovation is not as simple as just buying a new technology or implementing a new care model. Frankly, it can be overwhelming not just to see innovations through, but even to get started. So, what does it really take to innovate? And how do you align your organization’s challenges with the solutions or innovations that are being presented to you?

In this special episode, live from Advisory Board’s 2024 Clinical Innovation Summit, guest host and Advisory Board digital health expert John League invites Dr. Ayo Ajaiyeoba from Blue Cross Blue Shield of Kansas City, and Elliot Green, cofounder and CEO of Dandelion Health, to dive deep on the realities of innovation. Throughout the discussion, they explore what it takes to get started, how to act in the face of ambiguity, and how you should be thinking about tools like data and partnerships to achieve your goals.

Links:

More upcoming events from Advisory Board

How Cone Health added ATTR-CM screening to an existing care pathway: A TAVR example

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

216: Why providers and employers need to focus on women's health "beyond the bikini" Jul 16, 2024

It seems like a no-brainer for healthcare organizations to allocate time and attention to a health condition that is guaranteed to affect 50% of adults during their midlife years—but that hasn’t been the case.

We’re seeing momentum around making menopause mainstream—from the White House directing research funding, to Hollywood stars talking openly about menopause, to the rise of femtech companies geared toward helping consumers navigate the clinical and social effects of menopause. But though 100% of women in midlife will experience this clinical event, the reality is that most women’s health programs are primarily focused on what our guests have referred to in the past as the “bikini approach” to women’s health, and have largely ignored the needs of women in the post-reproductive years. From a clinical and financial standpoint, this is a missed opportunity. And given 80% of the healthcare workforce is women, and one-third of those women are in midlife, it’s also a competitive vulnerability.

That’s why this week, host Rachel (Rae) Woods invites Advisory Board women’s health experts Kara Marlatt and Gaby Marmolejos to explore how provider and employer leaders can build systems that account for and address women’s health needs “beyond the bikini.”

Links:

[Webinar, Aug. 13] Your guide to the lab and diagnostics market landscape in 2024

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

215: Why Walmart and other retailers are exiting primary care delivery and why it matters Jul 09, 2024

In recent years, we’ve seen large retailers like CVS, Walgreens, Walmart, and even Amazon add to their care delivery portfolios, specifically through offering low-acuity primary care services. But it seems like the tide may be shifting. In April, Walmart announced that it’s shuttering its primary care operations and virtual care arm—and it’s not the only one scaling back. The fact is, a number of retailers are retrenching on primary care operations.

In this episode, host Abby Burns invites Advisory Board experts Vidal Seegobin, Natalie Trebes, and Eliza Dailey to unpack exactly why Walmart and other retailers are pulling back on primary care delivery, and why the conventional explanation –"healthcare is too complex”– falls short.

Links:

[July 25] Understand your customer: Medical groups 101

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Behind the scenes: Our journey to four years, 1M downloads Jul 02, 2024

Radio Advisory first started production in April 2020 to deliver timely, critical messages to healthcare professionals navigating the early days of the Covid-19 pandemic.

Four years, 200+ episodes, and one million downloads later, Radio Advisory continues to bring insightful conversations and valuable insights to listeners passionate about driving positive change in healthcare.

To celebrate our millionth download, host Rachel (Rae) Woods and the Radio Advisory production team revisit some of their favorite episodes over the last four years, recollect the lessons learned, and reflect on how the healthcare industry has evolved alongside us.

We owe this milestone to you, our listeners. Your support and engagement have fueled and enriched our episodes, and we look forward to bringing you many more insightful conversations. Thank you!

Links:

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

214: Is Governance the answer to AI integration? Duke says yes. Jun 25, 2024

Generative AI is one of the most widely discussed topics in the industry today. There is continued excitement, mounting anxiety, and dozens of questions for health leaders to answer. While the healthcare industry has been working tirelessly to adapt to the almost unbelievable rate of change, many organizations struggle with how to ethically implement and scale Artificial Intelligence.

This week, host Rachel (Rae) Woods invites Duke University Health System's Chief Information Officer, Dr. Eric Poon, to discuss how Duke has approached ethical implementation of AI—and how their efforts started long before ChatGPT existed. Throughout the conversation, they discuss the early challenges Duke faced, offer tactical guidance for successful implementation, and explain why proper governance is critical to ethical AI adoption.

Links:

Using simplified clinical criteria to screen more patients for ATTR-CM

The challenges with migraine care — and what health systems can do about it

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

213: Radio Advisory Live: Why "value" doesn't have to be zero sum, with Stacey Richter Jun 18, 2024

The healthcare industry has been rocked by the pandemic and thrown headfirst into a new era of technological and therapeutic revolution. Yet, in the midst of all this change and uncertainty, healthcare leaders are expected not just to survive, but actually drive value for their organizations, patients, and communities. The problem is, “driving value” is not only complex, but it’s also ambiguous. Leaders who talk about value across the industry may not even be talking about the same thing. So, how should the industry think about driving value and what does it take to get this right?

In this episode, live from Advisory Board’s 2024 Value Summit, host Abby Burns invites Stacey Richter, healthcare entrepreneur, co-president of Aventria Health Group, and host of the Relentless Health Value podcast, to break down what “value” in healthcare actually means, where organizations go wrong, and how we can work to improve value across the industry.

Links:

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

212: Lessons from the C-Suite: Google's Chief Health Officer Dr. Karen DeSalvo on healthcare's cognitive industrial revolution Jun 11, 2024

The rise of generative AI has impacted healthcare in many ways – one of which is that it’s pushing Big Tech toward becoming not just a relevant, but a central player in the industry. And when we’re talking Big Tech, we have to include Google. Google’s activity in healthcare has been turbulent since it entered the space nearly two decades ago, but it’s impossible to deny the significance of the contributions it’s made to the industry.

Now with the rapid growth of genAI, Google is refining its healthcare strategy to drive maximum impact in the areas it’s best positioned to – places like consumer, therapeutics, diagnostics, and more.

At the forefront of this work is Dr. Karen DeSalvo, Google’s Chief Health Officer. This week, guest host Eric Larsen, President Emeritus of Advisory Board and President of Towerbrook Advisors sits down with Dr. DeSalvo to unpack the seemingly boundless opportunities of generative AI to evolve healthcare and the unique—and scoped—role Google is playing in helping advance that evolution.

Links:

The chronic condition we should be talking about: Challenges and opportunities in migraine care

3 takeaways on why primary care is key to migraine management

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

211: Pursuing financial sustainability in cell and gene therapy delivery Jun 04, 2024

So far in our series on bespoke care and innovation, we’ve delved into the future of cancer care and the opportunities for equity in precision medicine. But we can’t conclude our series without talking about one of the most exciting developments in the field: cell and gene therapies. We’ve talked about these therapies on the pod before—but like everyone else, we’ve primarily focused on the payment side of the equation and looked at how purchasers and pharma can work together to ensure patient access. These conversations miss the voice of a key stakeholder: providers.

What is the role of the provider organizations in realizing the value of cell and gene therapies? To answer that question, in the final episode of our series leading up to Advisory Board’s Clinical Innovation Summit: Revolutions in Specialty Care, host Rachel (Rae) Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to unpack how providers are grappling with how to get these life-changing treatments to those that need them.

Links:

Register for the Revolutions in Specialty Care Summit

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

210: How you approach precision medicine matters—for some patients more than others May 28, 2024

It's no secret that healthcare is becoming more and more personalized – or “bespoke” – as increasingly sophisticated diagnostics and therapeutics continue to explode into the market. This vast pipeline is redefining the industry in several ways—but there is real risk associated if the stakeholders responsible for developing, delivering, and paying for these innovations aren’t baking health equity into their business models.

Last week, in the first episode of our run up to the Advisory Board Clinical Innovation Summit: Revolutions in Specialty Care, we discussed Advisory Board’s prediction for the future of oncology. This week, host Rachel (Rae) Woods invites Advisory Board experts Amanda Okaka and Fanta Cherif to break down the health equity conundrum presented by precision medicine: Will precision medicine reduce health disparities, or exacerbate them? The answer depends on the actions—big and small—of industry leaders.

Links:

Register for the Clinical Innovation Summit

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

209: Predicting what oncology will look like in 2030 May 21, 2024

There has been a lot of change in the oncology space in the last few years. These changes have brought new pressures, like workforce strain, increased competition, rising spend, and more. While many leaders are worried about the "right now," it is crucial to consider how you can best position yourself for the future of cancer care.

That's why, in this episode, host Rachel (Rae) Woods invites Advisory Board specialty care experts Lindsey Paul and Julia Elder to discuss why preparing for the future means making changes today. Throughout the conversation, they discuss how current pressures are changing the field of oncology and four ways cancer care will change by 2030.

Links:

Register for the Clinical Innovation Summit

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

208: Authors Jim and Bob Rebitzer ask, "Why can't healthcare be better and cheaper?" (Live from The Players 2024 Championship) May 14, 2024

According to economist Jim Rebitzer and healthcare consultant Bob Rebitzer, the healthcare industry has failed in achieving what many other sectors have accomplished – improving products, while simultaneously reducing costs over time.

In this episode, recorded live at The Players 2024 Championship, host Rachel (Rae) Woods invited Jim and Bob to discuss the central premise of their book, Why Not Better and Cheaper? They discussed the root causes of this challenge – including incentives, prevailing professional and social norms, and competition – that the industry must confront to deliver better and cheaper healthcare.

Links:

Learn about Advisory Board On-Demand Courses

6 advantages to matching patients with compatible clinicians (sponsored by Optum Match)

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

207: Nurses Week 2024: Build care teams, not assembly lines May 07, 2024

Radio Advisory has commemorated Nurses Week every year since we started production in April 2020. A lot has changed since the early days of the pandemic, but the reality is that we’re still grappling with a workforce crisis defined by rising burnout, turnover, and shortages. Celebrating nurses just one week out of the year will not suffice in addressing these complex issues.

In this episode, host Rachel (Rae) Woods sits down with Advisory Board nursing experts Monica Westhead, Allyson Paiewonsky, and Ali Knight to discuss why the industry needs to pivot towards more sustainable strategies for their care teams, what leaders should be thinking about when training and supporting nurses, and why "top-of-license care" is an incomplete solution.

Links:

Truly personalized care is possible. Here's how to make it a reality.

[Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

206: 24th Secretary of HHS Alex Azar shares his vision on healthcare transformation Apr 30, 2024

As healthcare leaders continue to contend with workforce shortages, technological shifts, and fragile financials it can be hard to predict what the future looks like for their organizations and the transformation that needs to happen to improve healthcare for all.

In this episode, host Rachel (Rae) Woods invites the 24th Secretary of the U.S. Department of Health and Human Services Alex Azar to discuss what "transformation" actually means, what conditions need to be in place to mitigate financial loss, and what leaders can do to advance towards industry-wide transformation.

Links:

[Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

205: Live from ViVE 2024: Four leaders on how technology is redefining clinical work Apr 23, 2024

You might be burned out from talking about burnout. But the truth is, healthcare workers are still suffering from high administrative burden, reduced autonomy, and a cycle of turnover and retirements that we cannot escape. In response, industry leaders are looking to the latest and greatest technologies to unburden their workforce and improve the mental wellbeing of their staff. But will the promise of a tech-enabled clinical workforce live up to the hype?

In this special episode, recorded live from ViVE 2024, host Rachel (Rae) Woods invites Dr. Nele Jessel, Chief Medical Officer at athenahealth, Dr. Jesse Ehrenfeld, President of the American Medical Association, Dr. Syl Trepanier, SVP and System Chief Nursing Officer at Providence, and Dr. Tina Shah, Chief Clinical Officer at Abridge, to discuss the state of the workforce crisis, how new technologies are redefining work, and why emerging technologies like AI might not be a silver bullet.

Links:

[Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

204: Unveiling "Bespoke Care": Healthcare's tailored future Apr 16, 2024

High-cost drugs, generative AI, diagnostic testing – the pace and sophistication of healthcare innovation has been keeping our experts busy over the past several years. At some point, they realized there was something deeper going on – a sea change in what healthcare innovation is seeking to achieve, and the world it's pushing us toward.

This week, host Abby Burns invites Advisory Board innovation experts Solomon Banjo and Nick Hula to talk about a new era of innovation, where progress in diagnostics, treatments, data analysis, and ongoing management have the potential to revolutionize patient care through unprecedented customization. They define what "bespoke care" is, explain how it differs from other delivery models, and highlight the opportunities (and challenges) it presents.

Want to learn more about bespoke care and what it means for the industry? Register for our upcoming webinar series in May.

Links:

New advances in treatment and diagnostics have the potential to deliver on one of healthcare's greatest unrealized promises: truly personalized, patient-focused care. But how can a system designed to deliver fast, standardized treatment realign itself to offer "bespoke care" to patients at scale? Visit advisory.com/bespoke to learn 4 key challenges standing in the way – and how to overcome them.

Radio Advisory is celebrating its four-year anniversary this month! Tell us about your favorite episode, what you like about the podcast, and how we can continue to do better by emailing podcasts@advisory.com or leave us a voicemail through radioadvisory.advisory.com. Thanks for listening!

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

203: Value series: Is the future of VBC in specialty care? Zing Health & Strive Health say yes. Apr 09, 2024

Last week, in part two of our series on value-based care, we talked about how CenterWell, Humana’s provider arm, turned to senior-focused primary care to grow their value-based strategy. But as the Medicare Advantage market gets larger, older, and sicker, it is becoming clear that a focus on primary care isn’t enough. The fact is, VBC in specialty care is the future.

In part three of our value series, host Rachel (Rae) Woods invites TJ Ackerman, Senior Vice President of Provider and Network Performance at Zing Health, to discuss what good specialty care in Medicare Advantage looks like. We also talk with one of Zing’s provider partners, Will Stokes, Chief Strategy Officer at Strive Health, a leader in value-based kidney care. Together, TJ and Will discuss the importance of payer-provider partners in value-based specialty care.

Links:

Use the Market Scenario Planner

Learn about Advisory Board On-Demand Courses

Register for the Raising the Value Bar Summit

3 strategies for facing the 'tripledemic' of respiratory viruses

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

202: Value series: Why CenterWell (and Humana) is going all in on senior care Apr 02, 2024

Last week, in part one of our series on value-based care, we talked all about health systems taking on risk, and why that looks a bit different for everyone. This week, we're exploring an organization that embodies that principle. CenterWell, Humana's provider arm, is pursuing value-based care by going all in on senior focused care. So how are they doing it?

In part two of our value series, host Rachel (Rae) Woods invites CenterWell President, Dr. Sanjay Shetty, to discuss the philosophy behind and strategies for pursuing value-based care through senior care management. Throughout the conversation, they discuss why this strategy is right for CenterWell, what it takes to succeed, and how they are navigating today's market challenges.

Links:

3 strategies for facing the 'tripledemic' of respiratory viruses

How CoxHealth grew their Inspire program to meet surging demand

Learn more about On-Demand Courses

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

201: Value series: What does health system VBC adoption actually look like? Mar 26, 2024

In a few weeks, Advisory Board will be convening leaders across the industry in New Orleans, Louisiana to talk about the meaning of "value" in healthcare. In anticipation of the Value Summit, Radio Advisory will be spending the next three weeks talking about one major expression of value in the industry – value-based care.

In the first episode of our mini-series, host Abby Burns invites Advisory Board value-based care experts Clare Wirth and Daniel Kuzmanovich to paint the landscape of health system VBC adoption and break down why the road to VBC is neither linear, nor uniform.

Links:

How St. Cloud ENT partnered with an ASC to improve sleep apnea outcomes and grow surgical services

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

200: Why 2024 is a make-or-break year for corporate medical groups Mar 19, 2024

In the last five years, the health care industry has seen an explosion of corporate ownership over medical groups. It's been relatively smooth sailing for many of these groups so far—but in 2024, they may face the same challenges as incumbents.

In this episode, host Rachel (Rae) Woods invites Advisory Board physician experts Sarah Roller and Eliza Dailey to discuss why 2024 will be a make-or-break year for corporate medical groups, and what that means for the rest of the industry.

Links:

Use Advisory Board's Clinician Supply Profiler to see how physician supply in your market compares to others.

Register for Advisory Board's Clinical Innovation Summit and learn about sponsorship opportunities.

Learn more about Advisory Board Fellowship.

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

199: Why can't providers and plans just get along? Mar 12, 2024

Producers' note: We know a lot of organizations have been and are being affected by the major cyberattack of Change Healthcare systems and resulting outages. We won't be addressing it in this episode, but if you have questions or are looking for more information please go to https://www.unitedhealthgroup.com/changehealthcarecyberresponse.

The relationship between health plans and providers has always included an element of friction, but lately, it seems like the temperature is rising. And you've probably noticed – public contracting disputes increased by 69% between 2022 and 2023.

That's why, in this episode, host Abby Burns invites Advisory Board experts Max Hakanson and Eileen Fennell to discuss why the state of affairs seems to be getting worse, how key flashpoints are fanning the flames, and what each stakeholder says they need to see from their partners in order to mend the relationship. Plus, Advisory Board digital health expert Ty Aderhold makes a cameo appearance to help answer the question: Is AI the solution here?

Links:

2024 Raising the Value Bar Summit

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

198: PE firm General Catalyst is buying a hospital — here's our take Mar 05, 2024

Corporate entities like health plans, retail companies, and PE firms have aggregated large, diverse portfolios of care delivery assets over the past decade – with one notable exception: no one was buying hospitals.

But in January, venture capital firm General Catalyst bucked that trend and announced its intent to acquire Summa Health, a 3-hospital health system in northeastern Ohio. What are they thinking? And what could this mean for the industry?

In this episode, host Rachel (Rae) Woods and co-host Abby Burns invite Advisory Board's health system expert Vidal Seegobin to unpack the details of the story, interpret General Catalyst's ambition, and share what they'll be watching in the coming months.

Links:

The Hospital Benchmark Generator

Improving detection of ATTR-CM: Insights from experts

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

197: Lessons from the C-Suite: Demystifying generative AI with Dr. John Halamka, President of Mayo Clinic Platform Feb 27, 2024

Artificial intelligence has been rocking industries across the world, and healthcare is no exception. But what impact will it have exactly on physicians? Health systems? Data sovereignty?

In this episode, host Rachel (Rae) Woods passes the microphone to Eric Larsen, President Emeritus of Advisory Board and President of TowerBrook Advisors. In this conversation, Eric sits down with Dr. John Halamka, President of the Mayo Clinic Platform, to demystify how the industry should think about generative AI across all of healthcare.

Links:

Learn more about Advisory Board Sponsorship

Learn more about Advisory Board's 2024 Revolutions in Specialty Care Summit

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

196: The future of surgery (no, it's not just robots) Feb 20, 2024

Headlines about the future of surgery often focus on robots in the operating room– but innovation in surgical care and operations goes beyond robotics. In reality, the solutions to surgery leaders' problems – like inefficiency and dwindling margins – may be less futuristic than you'd think.

In this episode, host Rachel (Rae) Woods invites Advisory Board experts Isis Monteiro, Miles Cottier, and Paul Trigonoplos to discuss what is next for the future of surgery, and what it will actually take for health systems to make surgical care profitable again. They discuss innovations in the OR, opportunities to improve efficiency, and why it might be time to think differently about the future of surgery.

Links:

Use the Market Scenario Planner tool

Learn more about Advisory Board's 2024 Revolutions in Specialty Care Summit

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

195: Site-of-care shifts: It's time to go on offense Feb 13, 2024

The data doesn't lie: site-of-care shifts are accelerating. Health systems rely on surgical volumes as a major revenue driver, but as more procedures take place outside of the hospital, systems are not necessarily positioned to capture the shift in volumes – or revenues. So, what should health systems do?

To answer that question, host Abby Burns talks with Advisory Board experts Nick Hula and Sebastian Beckmann. They discuss why health systems need to transition from a "defensive" to "offensive" approach to capture shifting volumes and identify service- and market-level factors systems should consider when putting this mindset shift into action.

Links:

Learn more about Advisory Board's on-demand courses

Learn more about the Advisory Board Fellowship at: advisory.com/fellowship

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

194: The patients are not all right: Unpacking the quality crisis with The Joint Commission's Dr. David Baker Feb 06, 2024

We've all seen headlines about decreasing quality in U.S. healthcare. In an industry battling with workforce shortages, rising health needs, missed prevention, workplace violence, and rising healthcare needs, it's no wonder quality is falling and adverse events are rising. The fact is: in 2024, the patients are not all right.

In this episode, host Rachel (Rae) Woods talks with Advisory Board equity expert Darby Sullivan about the state of clinical quality. Following that, we hear from Dr. David Baker, Executive Vice President for Healthcare Quality Evaluation and Improvement at The Joint Commission, to discuss why patient quality is declining and what the industry can do to improve it. In the conversation, they discuss how we define and measure clinical quality, what leaders can do to improve outcomes, and more.

Links:

Learn more about Advisory Board's on-demand courses

How UPMC improved interdisciplinary care for metastatic breast cancer and geriatric patients

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

193: Is health system growth still possible? Jan 30, 2024

Between high labor costs, inflation, workforce shortages, and a host of other challenges, the past couple of years have been some of the most straining financial times for health systems in recent memory. Though the tides may be starting to turn, it is critical that health systems do not get complacent. How can health systems prepare to grow in the midst of an optimistic yet volatile landscape? Paradoxically, the growth path for health systems is actually to shrink.

That’s why, in this episode, host Rachel (Rae) Woods invites Advisory Board health systems expert Vidal Seegobin, and quantitative insights expert Larry Watts to discuss why heath systems might have to first shrink in order to grow and prepare themselves for the future. Throughout the conversation, they discuss why leaders need to look past the optimism of short term relief, and why hospital-based health systems need to start working smarter and not harder.

Links:

3 reasons to prioritize comprehensive sleep services

Need a quick answer to a healthcare question? Ask Advisory! Whether it's about where the market is headed, or how to navigate our website our team of experts are just a call or email away. Visit ask.advisory.com or email ask@advisory.com to learn more.

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

192: What CEOs need to know in 2024 (Part 2) Jan 23, 2024

Last week, in the first part of our series on what CEOs need to pay attention to in 2024, we discussed several of the seismic changes that have emerged in the healthcare industry. In particular, we discussed where care is delivered, and how the healthcare industry is shifting from hospital-first care delivery to vertically integrated ecosystems.

In part two of our series, host Rachel (Rae) Woods welcomes back Advisory Board experts Natalie Trebes, Prianca Pai, and Sharon Yuen to discuss two other seismic shifts: who delivers care and how it’s paid for. In the conversation, they discuss how care team roles are shifting in a world of generative AI, how treatment economics are evolving in the new era of bespoke care, and more.

Links:

Improving detection of ATTR-CM: Insights from experts

Learn about Advisory Board Sponsorship at advisory.com/sponsorship

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

191: What CEOs need to know in 2024 (Part 1) Jan 16, 2024

As we step into 2024, there is no denying that the healthcare industry is vastly different than it was 5 years ago, 1 year ago, maybe even one month ago. As the immediacy of the pandemic has ebbed, several other seismic changes have emerged that promise to transform the core of the healthcare industry. Understandably, healthcare leaders are concerned about the pressures they face today and those that lie ahead in 2024.

That's why, in part 1 of a two-part series on what CEOs need to know in 2024, host Rachel (Rae) Woods invites Advisory Board experts Natalie Trebes, Prianca Pai, and Sharon Yuen to unpack these seismic changes and discuss how leaders should be preparing for the future.

Links:

Learn about Advisory Board Sponsorship at advisory.com/sponsorship

Advisory Board On-Demand Courses

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

190: Behind the scenes with Rae & AskAdvisory Dec 19, 2023

Every year, Advisory Board receives thousands of questions from healthcare leaders about what's happening in the industry and how their organizations should respond. The team who answers these questions is called AskAdvisory – and today we're giving listeners a behind-the-scenes look at how these experts help leaders answer their most pressing questions.

In Part 1 of this episode, host Rachel (Rae) Woods invites some of our AskAdvisory colleagues to answer some of the questions they've received this year. Then, in Part 2, Rae invites Chris Phelps, lead producer of the Radio Advisory team, to give listeners an inside look on how we make Radio Advisory.

Links:

Follow Advisory Board on Instagram

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

189: A preview of Advisory Board's 2024 research Dec 12, 2023

With the new year just around the corner, we wanted to take some time to reflect on everything we've researched in the last twelve months and set our research agenda for the year ahead. In 2023, we spent a lot of time focusing on how to overcome a difficult financial landscape, what AI means for the future of healthcare, and how the industry should reckon with new high-cost drugs. But what will we be focusing on in 2024?

In this episode, guest host Rachel (Rae) Woods invites eleven (yes, you read that right) Advisory Board experts to discuss what exactly is on our radar in the new year and what you can expect to hear from us here at Radio Advisory throughout 2024.

Topics include:

(1:23) Strengthening care teams
(4:20) Generative AI
(6:44) Payer-provider partnerships
(10:02) Future of hospital sustainability
(11:57) Future of cancer care
(14:51) Financing and integrating innovation
(17:37) Ambulatory surgery center strategy
(20:19) Value-based care performance

Links:

3 takeaways from our latest webinar on AI in healthcare

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

188: The business case for investing in women's health Dec 05, 2023

Women experience healthcare differently compared to men – women consistently have worse outcomes when it comes to chronic diseases, feel unheard, and are oftentimes left out of education and research. Women's health also gets conflated with maternal health, but we know women's health is so much bigger than pregnancy.

Improving women's health outcomes requires a more holistic approach to caring for women, but allocating more dollars when working with limited resources may feel unsustainable to some organizations.

In this episode, host Rachel (Rae) Woods invites Advisory Board's Gaby Marmolejos, Kara Marlatt, and Ellie Wiles to discuss why there's a strong business case to better meet women's needs, including but not limited to maternal health.

Links:

[Infographic] How healthy is your structural heart program?

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

187: ChristianaCare's comprehensive, CFO-approved approach to behavioral healthcare Nov 28, 2023

It's no secret that the US is in the midst of a behavioral health crisis—and with the impacts of unmet need affecting every corner of the industry, many leaders are feeling powerless to sustainably address it.

In this episode, guest host Abby Burns invites ChristianaCare's Chief Biopsychosocial Officer, Erin Booker, to discuss how Erin is driving—and making the case for—a comprehensive and holistic behavioral healthcare strategy. Erin shares how she converted her CFO to be a champion for integrated behavioral healthcare, as well as how she approaches workforce challenges, partnership, and policy advancement.

Links:

Learn more about Advisory Board's on-demand courses

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

186: The new era of drugs is now Nov 21, 2023

In the past few months, we have talked a lot about high-cost drugs. We've done episodes on new innovations, equity implications, the rise of weight management drugs and more. While there is a lot to be excited about, there is a lot to be anxious about too, like high costs and impending legislation. A lot of the industry is tempted to "wait and see" what the new era of drugs will bring, but the reality is that "new era" is already here.

That's why, in this episode, host Rachel (Rae) Woods invites Advisory Board pharmacy experts Rachael Peroutky and Chloe Bakst to discuss how the industry should be thinking about this new era of drugs, and why healthcare organizations can't afford to sit around today and strategize later.

Links:

Read Advisory Board's case study about how University of Michigan Health-West improved clinician well-being with Nuance's Dragon Ambient eXperience (DAX).

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

185: AI adoption: why you can't afford to "wait and see" Nov 14, 2023

It is no question that we are in an unprecedented era of technological change. Large language models and the rise of generative AI have dominated industry conversations in recent months, and for good reasons. It's clear that AI is here to stay, but what isn't so clear is how the industry should adopt it. Should you run headfirst into experimentation? Or wait for data and case studies before implementation?

In this episode, host Rachel (Rae) Woods invites Advisory Board digital health experts Ty Aderhold and Elysia Culver to discuss how the industry needs to be thinking about AI adoption and integration. Throughout the conversation, they discuss what we can (and cannot) learn from past technologies, what it means to be an "early mover" or "fast follower," and why taking an incremental approach can empower your business strategy.

Have a healthcare question? Want to learn more about what goes on behind-the-scenes at Radio Advisory? Submit your question and we may use it in our final episode of 2024! Email podcasts@advisory.com or leave us a voice message by Thanksgiving for consideration. Thanks!

Links:

Visit advisory.com/AIstrategy to learn what's necessary for AI to drive transformative outcomes in the healthcare landscape.

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

184: Coverage whiplash: the headache of Medicaid redeterminations and how to respond Nov 07, 2023

During the COVID-19 Public Health Emergency, the federal government and insurers implemented several measures to expand coverage options and better ensure ease of access to healthcare services. One of the most significant policies was the expansion of Medicaid programs and the requirement that individuals be continuously enrolled through the end of the PHE. The expanded eligibility ended when the PHE expired in May 2023, and the industry is reeling from the whiplash of coverage changes. In this episode, host Rachel (Rae) Woods invites Advisory Board health plan experts Chelsea Needham and Sally Kim to discuss what you need to know about Medicaid redeterminations, how health plans are responding, and what this means for the healthcare industry.

Have a healthcare question? Want to learn more about what goes on behind-the-scenes at Radio Advisory? Submit your question and we may use it in our final episode of 2024! Email podcasts@advisory.com or leave us a voice message by Thanksgiving for consideration. Thanks!

Links:

Visit advisory.com/expertsupport to learn how you can bring Advisory Board experts to your organization to deliver presentations, workshops, and more on AI and other topics that keep healthcare leaders up at night.

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

183: John Muir Health and Optum reflect on what makes their partnership work Oct 31, 2023

As healthcare organizations look for ways to weather financial hardships, many leaders are looking at strategic partnerships to sustain their business. The word "partnership" gets thrown around a lot in healthcare and can mean a lot of different things. But what defines a good partnership, and how do you know if one is right for your organization?

In this episode, Host Rachel (Rae) Woods invites John Muir Chief Strategy Officer George Sauter and President of Optum's Market Performance Partnership Chris Pass to discuss why they decided to partner back in 2019, what they've gained, where they had to compromise, and how they define success.

Have a healthcare question? Want to learn more about what goes on behind-the-scenes at Radio Advisory? Submit your question and we may use it in our final episode of 2024! Email podcasts@advisory.com or leave us a voice message by Thanksgiving for consideration. Thanks!

Links:

Join Advisory Board for a webinar on November 13 at 1pm EST to learn about recent trends and growing capabilities in remote patient monitoring. Click here to learn more.

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

182: Should your partnership strategy go global? Oct 24, 2023

In recent years the delivery system has been strapped, to say the least. Any opportunity for financial stabilization and revenue diversification are sitting top of mind for provider executives. One place organizations are searching for lifelines is overseas, as more and more health systems are partnering internationally. No, it’s not just med tech and life sciences going global – health systems are looking overseas to advance their business objectives as well.

In this episode, host Rachel (Rae) Woods invites Advisory Board international experts Paul Trigonoplos and Isis Monteiro to discuss why interest in global partnerships are accelerating, how organizations are leveraging these partnerships, and whether it’s a good idea for all health systems to go global.

Ask us a question and hear it on the pod! Email us at podcasts@advisory.com, visit ask.advisory.com, or leave a voicemail at radioadvisory.advisory.com.

Links:

Join Advisory Board experts on Thursday, November 2 at 1 p.m. ET for a webinar where you’ll learn everything you need to know about the different types of AI, how these technologies are being used by healthcare organizations, common implementation pitfalls – and how to avoid them. Visit advisory.com/AIstrategy and register now.

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

181: Does healthcare's approach to obesity harm patients? Oct 17, 2023

In recent decades, billions of dollars have gone towards programs aimed at curbing obesity in the U.S., yet the prevalence of obesity remains high. Weight management drugs like Ozempic and Wegovy have come to public awareness recently, though these drugs are often expensive and hard to access, leaving patients to receive the industry's traditional approach to weight management. But are these approaches even helpful?

In this episode, host Rachel Woods invites health equity expert Darby Sullivan and pharmacy expert Chloe Bakst to discuss how the healthcare industry thinks about weight management, why the current approaches may be doing more harm than good, and how healthcare leaders need to think differently about treating obesity and weight.

Ask us a question and hear it on the pod! Email us at podcasts@advisory.com, visit ask.advisory.com, or leave a voicemail at radioadvisory.advisory.com.

Links:

Learn about Advisory Board Sponsorship at advisory.com/sponsorship

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

180: Tom Lawry on why AI has a PR problem Oct 10, 2023

In last week's episode, we discussed why technology is a non-negotiable tool for alleviating the workforce crisis. While we talked about many technologies, we didn't talk much about one of the most transformational forces in the healthcare industry today: Artificial Intelligence. There is so much buzz, and so much fear about the topic, that we wanted to dedicate an episode to it.

In this episode host Rachel (Rae) Woods invites back fan-favorite guest Tom Lawry, a top thought leader on artificial intelligence, bestselling author, and the former head of AI for Microsoft. Last year, Tom was part of an award-winning Radio Advisory episode on bias and AI. In this episode, Rae and Tom will discuss frustrations, fears, and the wealth of opportunities that generative AI brings the healthcare industry. They also discuss myths around AI, and why leaders should stop worrying about existential threats and start imagining the existential opportunity this technology provides.

Links:

Visit advisory.com/AI101 to learn more about Advisory Board's upcoming AI and Generative AI 101 webinar.

Learn more about how you can make the best use of AI and prepare your organization for the future with Advisory Board's Expert Support.

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

179: Future-proofing healthcare requires a tech-enabled workforce Oct 03, 2023

It's no secret that the industry is in the midst of a serious workforce crisis. For years, leaders have employed strategies primarily looking to mitigate the crisis with short-term solutions without addressing the root-causes of clinician burnout and workforce shortages. However, today we want to talk about a non-negotiable tactic that can work to address these root problems: technology.

In this episode, host Rachel (Rae) Woods invites Advisory Board experts Allyson Paiewonsky and Jordan Peterson to discuss what organizations are getting wrong about tech and how it can work to sustainably alleviate the workforce crisis in the long term. Throughout the conversation, they discuss emerging technologies, why the industry needs to think differently about workforce solutions, and how leaders can work with the resources that they already have.

Links:

Learn more about the Advisory Board Fellowship at: advisory.com/fellowship

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

178: What the industry is (still) getting wrong about value-based care Sep 26, 2023

Value-based care has been dominating industry conversations in recent years. Here on Radio Advisory, we talk a lot about best practices, how to make the right investments, and how to best prepare leaders for the future of value-based care. But given all this momentum, we want to spend time asking the question: what are the misconceptions or misaligned expectations that leaders have around value-based care?

In this episode, host Rachel (Rae) Woods invites Advisory Board value-based care expert Daniel Kuzmanovich and Optum Advisory Service's SVP of value-based care, Erik Johnson, to discuss the mindset shifts they think leaders should be making when pursuing a sustainable value-based care strategy. Throughout the conversation they discuss what leaders are currently getting wrong, how myths about value-based care are impacting the industry, and more.

Links:

Learn more about Advisory Board's value-based care on-demand courses

Explore what volumes and revenues a structural heart program could capture in different scenarios, with Advisory Board's new calculator, sponsored by Edwards Lifesciences.

Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

177: Advancing equity in a world of innovation for some, costs for all: Live from the 2023 Clinical Innovation Summit Sep 19, 2023

With so many clinical innovations abound, it's easy to get excited about groundbreaking drugs, consumer technologies and even possible cures for rare diseases. However, the industry must recognize its own limitations in order to make these advancements accessible and equitable.

At the end of August, hundreds of healthcare leaders gathered at Advisory Board's Clinical Innovation Summit in Minneapolis to learn about the implications of the transformation of patient care across the industry. The Radio Advisory team orchestrated a live podcast recording with thought leaders across the industry to talk about embedding equity in innovation.

In this special live episode of Radio Advisory, host Rachel (Rae) Woods invites Maia Laing, SVP of Health Equity for UnitedHealth Group, and Michael Mejia, Advisory Board's director of life sciences research, to discuss how leaders can think about deploying, designing, and financing clinical innovations in an equitable way. Throughout the conversation, they discuss how payers and providers – not just life sciences – can rethink their practices to ensure advancements in innovation are shared equitably.

Links:

Dive into topics like AI and weight management drugs at Advisory Board’s Virtual Clinical Innovation Summit, coming up on October 4-5. Learn more and register.
7 trends shaping life sciences strategies in 2023
Health Equity landing page
Learn more about Advisory Board Summits

Need a quick answer to a healthcare question? Ask Advisory! Whether it's about where the market is headed, or how to navigate our website our team of experts are just a call or email away. Visit ask.advisory.com or email ask@advisory.com to learn more.

Advisory Board is a subsidiary of UnitedHealth Group. All Advisory Board research, expert perspectives, and recommendations remain independent.

176: Test, fail, and test again: Morgan Health's approach to employer costs Sep 12, 2023

With rising costs and tightening margins, the industry is continually looking for ways to "bend the cost curve" while maintaining, or even increasing, quality and performance. One stakeholder in particular, employers, are feeling significant pressures from inflation, hospital consolidation, the rise of high-cost drugs, and more. While many legacy cost-saving strategies have focused on reducing employer costs, it may be time to shift focus to lowering costs for employees as well.

In this episode, host Rachel (Rae) Woods invites Advisory Board payer expert Max Hakanson and Innovation lead at JPMorgan's Morgan Health Rivka Friedman to discuss what employers can do to rein in healthcare costs, both for themselves and their employees. Throughout the discussion, they discuss why legacy cost-sharing strategies may be insufficient, and what new innovations are showing promise in the market.

Join Rae for a free webinar on Advisory Board's State of the Healthcare Industry. In this webinar, you'll get Advisory Board’s exclusive take on the strategic forces that really matter. Rae will talk about the rise of artificial intelligence and why you should not be asking "what should my AI strategy be?". Save your seat and join Rae on September 18th at 2:00 PM ET.

Links:

Need a quick answer to a healthcare question? Ask Advisory! Whether it's about where the market is headed, or how to navigate our website our team of experts are just a call or email away. Visit ask.advisory.com or email ask@advisory.com to learn more.

From the See You Now podcast: Reckoning with Racism (Part 1) Sep 05, 2023

This week’s episode comes from one of our favorite healthcare podcasts, See You Now, which shines a light on the real people changing the status quo in health, created in collaboration with Johnson & Johnson and the American Nurses Association.

Racism in America remains pervasive. It’s led to sicker, shorter lives for people of color; a healthcare workforce that hasn’t reflected the communities it cares for; and caused harm to nursing and nurses, particularly nurses of color. Aware of its own role in perpetuating systemic racism, the American Nurses Association (ANA) is on a journey of racial reckoning along with many partners inside and outside of nursing and healthcare. In this two-part episode, we hear from leaders in nursing, media, and life sciences industry about how they are leaning into racial reckoning in their organizations to address and eliminate the harms of racism.

In Part I, Shawna Butler, RN MBA and co-host Lucinda Canty, PhD, CNM, FACNM engage in thoughtful and forthright dialog with Cheryl Peterson, MSN, RN about the ANA's Racial Reckoning Statement; how it led to the creation of the National Commission to Address Racism in Nursing; and the work the ANA has committed to in moving forward to antiracist practices, policies, and nursing profession.

Links:

[See You Now] Episode 91: Reckoning with Racism (Part I)
Shawna Butler, RN MBA
Lucinda Canty, PhD, CNM, FACNM
Cheryl Peterson, MSN, RN
Visit the See You Now podcast site: www.seeyounowpodcast.com
Free CNE's from the ANA for listening to See You Now episodes

Episode-specific resources:

Advisory Board resources on health equity and racism:

Our health equity and racism Playlist

4 ways to develop a 'speak up' culture at your organization

Health Equity landing page

The time is now to invest in your BIPOC leaders. Build an inclusive leadership team with Advisory Board Fellowship.

Learn more about Advisory Board on-demand courses

[Rerun] Senior Care (Part 2): The rapid growth of Medicare Advantage Aug 29, 2023

This week, we are revisiting episode 2 of our "Senior Care Series" from February 2023. This episode is still very relevant, but we do have some important updates that we’ve included at the beginning.

Medicare Advantage is a public-private hybrid health plan that allows eligible seniors to receive health insurance through a commercial insurer. It has a high satisfaction rate among enrollees and has crested more than fifty percent of all Medicare enrollment this year. In part two of Radio Advisory's senior care series, host Rachel (Rae) Woods provides an update on new policies and regulatory scrutiny that are impacting the program. We also will revisit her conversation with senior care expert Aaron Hill and health plan expert Max Hakanson about why Medicare Advantage is so popular and its impact on industry stakeholders.

Links:

Take our RN workforce survey at: advisory.com/RNsurvey

[Rerun] The dire state of hospital finances (Part 1: Hospital of the Future series) Aug 22, 2023

This week, we are revisiting episode 1 of our "Hospital of the Future series” which was initially released all the way back in November 2022.

The majority of hospitals are predicted to have negative margins in 2022, marking the worst year financially for hospitals since the beginning of the Covid-19 pandemic. In Part 1 of Radio Advisory’s Hospital of the Future series, host Rachel (Rae) Woods invites healthcare business experts Monica Westhead, Aaron Mauck, and Colin Gelbaugh to discuss why factors like workforce shortages, post-acute financial instability, and growing competition are contributing to this troubling financial landscape and how hospitals are tackling these problems.

Links:

Take our RN workforce survey at: advisory.com/RNsurvey

175: We need to talk about maternal health in America [Bonus content] Aug 15, 2023

(New/bonus content starts at 24:11. First part of episode originally aired October 5, 2021.)

This week, Radio Advisory is bringing you an encore of Ep. 91: We need to talk about maternal health in America, where host Rachel (Rae) Woods invites Advisory Board Expert Darby Sullivan and Optum Director of social responsibility Callie Chamberlain to discuss the dire state of maternal health in America.

Following the original episode, in a special bonus segment, host Rae Woods brings back Advisory Board health equity expert Darby Sullivan and invites women’s health expert Gaby Marmolejos to discuss why maternal health, and women’s health more broadly, are only getting worse. In the conversation, they discuss what is driving poor maternal outcomes and why there needs to be a massive shift in how the industry thinks about maternal health moving forward.

This episode was recorded before the FDA approved Zurzuvae (zuranolone), the first ever pill to treat post-partum depression. Postpartum depression is a condition that affects one in eight new mothers. Previously, the only treatment available was an IV infusion approved by the FDA, which required patients to be in the hospital for 2.5 days. The move underscores the industries' need to focus on behavioral health in the postpartum period and on women’s health more broadly.

Links:

[Webinar] Consumer insights decision makers should lead with in 2023 (August 24 | 3-4pm ET)

Visit advisory.com/workforce to get research and insights that will help you understand the current challenges providers are facing and learn how technology – including platforms you may already have – can address healthcare's biggest staffing and care delivery challenges.

Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

174: Quest's vision for genomics at scale Aug 08, 2023

In recent years, there has been a major influx of new genetic tests that have hit the market. While these tests promise to revolutionize diagnostics and treatment decision-making, the industry needs to overcome a variety of reimbursement and logistical barriers to achieve any goals for genomics at scale.

In this episode, guest host and Advisory Board expert partner Devin Airey invites Mark Gardner, the SVP of Genomic Medicine and Oncology at Quest Diagnostics, and Dan Edelstein, President and CEO of Haystack Oncology, to discuss their vision for genomics at scale. Throughout the conversation, they discuss increased attention from providers and purchasers, how to integrate new genomics technology into patient care, and how to address opportunities and concerns in the market.

Links:

173: 4 ways to prevent a physician shortage [Bonus content] Aug 01, 2023

(New/bonus content starts at 19:50.)

This week, Radio Advisory is bringing you an encore edition of 4 ways to prevent a physician shortage, which originally aired in May 2022. Host Rachel (Rae) Woods invites Advisory Board experts Daniel Kuzmanovich and Sebastian Beckmann to discuss the threats and realities of a physician shortage.

Following the original podcast, in a special bonus segment, host Rae Woods passes the mic to Eliza Dailey and Sydney Moondra to discuss how Advanced practice providers (APPs) are, and will continue to, radically transform the physician landscape.

Links:

Learn more and register for the 2023 Advisory Board Clinical Innovation Summit [August 22-23, 2023]

172: Build a value-based enterprise: Live from 2023 Value-Based Care Summit Jul 25, 2023

While value-based care has been at the forefront of industry conversations in the last decade, there are still a lot of questions about how to successfully create and thrive as a value-based enterprise.

At the end of June, around 300 healthcare leaders gathered at Advisory Board’s Value-Based Care Summit with one shared goal: make the next 10 years of VBC more impactful from the last. As part of the event, the Radio Advisory team orchestrated a live podcast recording with three renowned leaders at the helm of very different organizations – all trying to build value-based enterprises.

In this special live episode of Radio Advisory, host Rachel (Rae) Woods invites Rob Mayer, senior vice president and GM of Optum Insight Clinical Solutions; Laurie Sicaeros, Chief Strategy Officer at Memorial Care Health System; and Rushika Fernandopulle, Co-Founder and Former CEO of Iora Health, to discuss building a value-based enterprise, what defines success, and what capabilities and assets are needed to succeed.

Links:

Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

171: Data privacy in the wake of Dobbs Jul 18, 2023

In the last two weeks, we discussed the use of consumer data and how the FTC is using its power to respond to data privacy concerns. While there are stakeholders who are taking action in response, we wanted to explore a key question: what happens when the concerns raised are left unchecked? Following the 2022 Dobbs v. Jackson decision that overturned Roe v. Wade, we seem to have a test case.

In part three of Radio Advisory’s series on consumer data, host Rachel Woods invites Advisory Board experts Ty Aderhold and John League to discuss how the Dobbs decision impacts conversations around data privacy and how healthcare leaders should be thinking about protecting patient reproductive data.

Links:

170: Data privacy and the FTC: Who is working to protect your data? Jul 11, 2023

In the last episode, we discussed how different industry stakeholders are taking advantage and navigating the challenges of the use of consumer data in healthcare. While the industry wrestles with some concerns about data privacy, the question remains: who is working to protect the data of consumers and patients?

In part two of Advisory Board’s series on consumer data, host Rachel Woods invites Advisory Board experts Ty Aderhold, Sara Zargham, and Paul Trigonoplos to discuss one stakeholder that is making moves to protect data privacy: the FTC. In the conversation, they explore recent regulatory actions taken by the FTC and what this means for the industry.

Links:

Check out this recent Advisory Board blog post about how to address 5 common challenges seniors face in cancer care

169: Innovative or invasive? How consumer data is changing healthcare Jul 04, 2023

For years, consumers have felt the effects of the increased use of their data. From receiving targeted advertisements to personalized recommendations online, it is no secret that giants in various industries are taking advantage of complex consumer data. But how does this look in the healthcare space?

In part one of a new three-part series on consumer data, host Rachel Woods invites Advisory Board experts Solomon Banjo and Ty Aderhold to discuss how various industry players are taking advantage and navigating the challenges of the use of consumer data in healthcare. In the conversation, they explore exactly what kind of information is being used, what this means for various stakeholders, and how the rising use of consumer health data is poised to radically change the industry.

Links:

Learn more about Advisory Board’s upcoming webinar on key innovations in cancer care for patients by visiting https://www.advisory.com/resources/events

168: Having the tech isn't enough: the future of clinical decision making Jun 27, 2023

For years Advisory Board has been researching how technology and macro-economic forces are shaping clinical decision-making, and recent advances in large language models and AI have the potential to make an impact like we’ve never seen before. In this episode, guest host and Advisory Board life sciences expert Soloman Banjo invites Advisory Board expert Amanda Okaka and Optum’s Senior Vice President of Clinical Innovation Dr. Kevin Larson to discuss the technologies that will change clinical decision-making in the next decade, its implications, and what organizations should be thinking about as they integrate them into clinical workflows.

Links:

Learn more about Advisory Board’s upcoming webinar on key innovations in cancer care for patients by visiting https://www.advisory.com/resources/events

Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

167: How nervous should we be about high-cost drugs? Jun 20, 2023

With a variety of new (and expensive) therapies in the pipeline for 2023, it is understandable that the industry is feeling anxiety over the rise of high-cost drugs. However, there is not one-size-fits all solution. Industry stakeholders must consider and respond differently to each drug type.

In this episode, host Rachel (Rae) Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to discuss how industry stakeholders are thinking about different high-cost drugs and how they can prepare for the future.

Links:

166: Employer series: The role of employers in value-based care Jun 13, 2023

Last week we discussed the current state of employer-sponsored insurance and the affordability challenges that the employers are facing. This week, we'll be taking a look at one possible solution for employers: value-based care.

In this episode, host Rachel (Rae) Woods invites Advisory Board value-based care experts Daniel Kuzmanovich and Sophia Hurr to discuss the opportunity that value-based care presents for employers to reduce the costs of care while increasing the quality of care their employees receive. Throughout the conversation, they explore what kinds of employers are best positioned to pursue value-based care, and the different paths to get there.

Links:

Learn more about Advisory Board Events at advisory.com/resources/events

165: Employer series: Is the cost of employer-sponsored insurance unsustainable? Jun 06, 2023

While always facing a dynamic landscape, one of the biggest issues today in the employer-sponsored insurance market is affordability. As healthcare costs continue to rise, employers are getting increasingly nervous about their ability to pay for employees’ health insurance, especially in a time of heightened worker shortages.

In this episode, guest host and Advisory Board Vice President and spokesperson Aaron Mauck discusses employer market affordability with Advisory Board health plan experts Sally Kim and Max Hakanson. Throughout the conversation, they explore the context of the problem, root causes, and what the future may look like for employer-sponsored insurance.

Links: